We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.27%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.59B
AUM Growth
-$78.5M
Cap. Flow
-$53.5M
Cap. Flow %
-1.49%
Top 10 Hldgs %
13.47%
Holding
1,643
New
159
Increased
579
Reduced
611
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$52.5M
2
AFL icon
Aflac
AFL
+$24.1M
3
WLY icon
John Wiley & Sons Class A
WLY
+$18.9M
4
KMX icon
CarMax
KMX
+$17.5M
5
BIIB icon
Biogen
BIIB
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.39%
2 Energy 10.37%
3 Financials 10.35%
4 Technology 9.89%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMT
1101
PennyMac Mortgage Investment
PMT
$822M
$292K 0.01%
16,748
+101
+0.6% +$1.97K
CHN
1102
DELISTED
China Fund
CHN
$291K 0.01%
14,650
+4,150
+40% +$88.2K
MGA icon
1103
Magna International
MGA
$18.7B
$291K 0.01%
5,194
-108
-2% -$6.01K
TSLF
1104
DELISTED
THL CREDIT SENIOR LOAN FUND
TSLF
$290K 0.01%
17,250
+5,000
+41% +$91K
FPF
1105
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.07B
$288K 0.01%
13,382
-3,500
-21% -$78.3K
HAS icon
1106
Hasbro
HAS
$13.3B
$288K 0.01%
3,856
-1,498
-28% -$107K
MDD
1107
DELISTED
SPDR S&P INTERNATIONAL MID CAP ETF
MDD
$288K 0.01%
+9,330
New +$300K
ANIP icon
1108
ANI Pharmaceuticals
ANIP
$1.8B
$287K 0.01%
4,630
-2,269
-33% -$135K
IJJ icon
1109
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
$287K 0.01%
4,450
-1,284
-22% -$84.8K
NDRM
1110
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$287K 0.01%
18,708
-992
-5% -$14K
TLH icon
1111
iShares 10-20 Year Treasury Bond ETF
TLH
$10.9B
$286K 0.01%
2,148
+657
+44% +$88.9K
PPA icon
1112
Invesco Aerospace & Defense ETF
PPA
$8.24B
$285K 0.01%
8,071
PRXL
1113
DELISTED
Parexel International Corp
PRXL
$285K 0.01%
4,439
-304
-6% -$20.5K
NDSN icon
1114
Nordson
NDSN
$16.6B
$283K 0.01%
3,636
+370
+11% +$29.8K
IYZ icon
1115
iShares US Telecommunications ETF
IYZ
$1.2B
$282K 0.01%
9,625
+5
+0.1% +$152
HEP
1116
DELISTED
Holly Energy Partners, L.P.
HEP
$282K 0.01%
8,029
+960
+14% +$31.9K
SYNH
1117
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$281K 0.01%
+7,001
New +$242K
IFN
1118
Aberdeen India Fund
IFN
$499M
$280K 0.01%
10,578
-1
-0% -$27
STLA icon
1119
Stellantis
STLA
$16.7B
$280K 0.01%
29,556
-6,337
-18% -$65K
VIAV icon
1120
Viavi Solutions
VIAV
$9.12B
$280K 0.01%
42,598
-17,951
-30% -$131K
TGP
1121
DELISTED
Teekay LNG Partners L.P.
TGP
$280K 0.01%
8,683
-2,896
-25% -$105K
STM icon
1122
STMicroelectronics
STM
$46.7B
$279K 0.01%
34,400
+3,400
+11% +$29.2K
ALL icon
1123
Allstate
ALL
$68B
$278K 0.01%
4,280
-1,729
-29% -$119K
EOT
1124
Eaton Vance National Municipal Opportunities Trust
EOT
$270M
$278K 0.01%
13,800
+4,150
+43% +$86.9K
RFI
1125
Cohen & Steers Total Return Realty Fund
RFI
$308M
$278K 0.01%
+22,800
New +$296K

Similar funds

Oppenheimer & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Oppenheimer & Co held 1,643 positions worth $3.59B, down 2.1% from $3.67B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q2 2015 filing shows 159 new, 579 increased, 611 reduced and 173 closed positions. Its largest new stake was Southwestern Energy Company: 251,114 shares worth $5.71M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Energy and Financials.

  • Oppenheimer & Co's largest Q2 2015 buy was Southwestern Energy Company: 251,114 shares worth $5.71M.
  • Oppenheimer & Co added most to Gilead Sciences in Q2 2015, an estimated $52.5M increase.
  • Oppenheimer & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $70.4M.
  • Oppenheimer & Co fully exited Vanguard Total Bond Market in Q2 2015, selling an estimated $12.6M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.59B portfolio in Q2 2015.
  • Oppenheimer & Co opened 159 new positions and closed 173 in Q2 2015.
  • Oppenheimer & Co's portfolio value fell 2.1% quarter-over-quarter to $3.59B.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.